The proposal, House Bill 1910, does not provide for funding from the state, but it stipulates the opioid antagonists may be ...
SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
President Trump suspended tariffs intended to stop fentanyl from entering the United States. Here’s what to know about the ...
Opioid antagonists like naloxone, which counteract the effects of an opioid overdose, are another example of harm reduction. The medicine can be injected with a needle or ingested via nasal spray.
These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly ...